%A Srinivasalu, Vijay %A Pavithran, Keechilat %T Biomarkers in colon cancer and its clinical implications %9 Review Article %D 2020 %J Journal of Current Oncology %R 10.4103/jco.jco_38_20 %P 66-71 %V 3 %N 2 %U http://www.https://journalofcurrentoncology.org//article.asp?issn=2589-8892;year=2020;volume=3;issue=2;spage=66;epage=71;aulast=Srinivasalu %8 July 1, 2020 %X Colorectal cancers have been a major burden in our society, with nearly 20,000 deaths in a year. Most of the patients are diagnosed with metastatic disease at presentation and have shorter survival despite the best effective treatment. The detection of novel targets and predictive biomarkers has changed the treatment paradigm, resulting in improved quality of life and prolonged survival in these patients. However, the identification of an ideal biomarker has been a major challenge and a quest for better biomarkers to detect premalignant lesions, early-stage cancers; to identify high-risk subsets who derive maximum benefit from adjuvant chemotherapy and minimize unnecessary chemo-toxicity; to identify newer targeted therapies in advanced stage to improve clinical responses; and to provide personalized treatments that would significantly help in improving survival outcomes. In this review article, we provide an overview of the biomarkers with clinical importance and an update on newer noninvasive, sensitive, and clinically reliable biomarkers in development. %0 Journal Article %I Wolters Kluwer Medknow Publications %@ 2589-8892